Nav: Home

Annals publishes annual updates in internal medicine

March 30, 2017

Annals of Internal Medicine, the flagship journal of the American College of Physicians (ACP), has published summaries of the most important medical studies published in 2016 in the fields of general internal medicine, cardiology, hematology, endocrinology, gastroenterology and hepatology, rheumatology, and perioperative, pulmonary, and geriatric medicine. All articles were published within the last year in some of the world's most prestigious medical journals. Authors in each topic area chose articles based on novelty and quality of the research, as well as potential impact on clinical practice.

Publication of the updates coincides with Internal Medicine Meeting 2017 (hashtag #IM2017) the annual scientific meeting of the ACP, taking place March 30 - April 1 in San Diego. Each "Update" includes detailed summaries of several articles pertaining to a particular subspecialty of internal medicine. Highlights from each subspecialty include:
  • General Internal Medicine: An article published in Annals of Internal Medicine found that smokers who quit abruptly were more likely to quit successfully. Cochrane Database of Systematic Reviews published a study showing that acetaminophen did not reduce pain or disability in acute nonspecific low back pain.

  • Women's Health: An article in Annals of Internal Medicine found that low-dose aspirin is modestly beneficial for preventing cardiovascular events and colorectal cancer in high-risk women as well as men. An article in the Journal of the National Cancer Institute found that women who were vaccinated for the human papillomavirus (HPV) could extend the cervical cancer screening interval.

  • Cardiology: An article published in JAMA Internal Medicine found that industry-funded research suppressed evidence of the role of sugars as a risk factor for coronary artery disease. A second article in JAMA Internal Medicine found that eating more plant protein and less animal protein was associated with less cardiovascular disease and a lower risk for death.

  • Hematology and Oncology: An article in the New England Journal of Medicine found that active surveillance may be a reasonable option for many men with prostate cancer. No difference in mortality was observed at 10 years among patients undergoing active surveillance, surgery, or radiation therapy for localized prostate cancer. An article in Annals of Internal Medicine found that use of an age-adjusted D-Dimer level with a low-likelihood Wells score led to an increased number of patients in whom imaging could be withheld.

  • Critical Care Medicine: An article in the Journal of the American Medical Association found that too much oxygen could be harmful in patients with respiratory failure. An article in the American Journal of Respiratory Critical Care Medicine found that a continuous infusion of β-Lactam antibiotics may reduce hospital mortality in severe sepsis.

  • Rheumatology:Arthritis & Rheumatology published an article suggesting that vaccination for herpes zoster may benefit patients with autoimmune conditions at younger ages than stated in current guidelines. Annals of the Rheumatic Diseases published an article that showed statin use may lower mortality risk in patients with rheumatoid arthritis.

  • Hospital Medicine: An article published in JAMA Internal Medicine showed that antipsychotic medications resulted in prolonged and more severe delirium among terminally ill hospitalized patients. An article in Annals of Internal Medicine showed that hospital readmission rates decreased after federal law levied financial penalties for readmissions.

  • Pulmonary Medicine: An article published in Thorax found that pulmonary rehabilitation at home was as effective as a facility-based program for patients with COPD. The home-based intervention had a lower coast and higher adherence rates. An article published in the New England Journal of Medicine found that CPAP treatment did not prevent cardiovascular events in patients with obstructive sleep apnea.
About Annals of Internal Medicine

Annals of Internal Medicine is one of the most widely cited and influential medical journals in the world, with an impact factor of 16.593 -- the highest of any specialty journal in its category. Annals' mission is to promote excellence in medicine, enable physicians and other health care professionals to be well-informed members of the medical community and society, advance standards in the conduct and reporting of medical research, and contribute to improving the health of people worldwide. Established in 1927, Annals is the flagship journal of the American College of Physicians (ACP).

American College of Physicians

Related Prostate Cancer Articles:

ASCO and Cancer Care Ontario update guideline on radiation therapy for prostate cancer
The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario today issued a joint clinical practice guideline update on brachytherapy (internal radiation) for patients with prostate cancer.
Patient prostate tissue used to create unique model of prostate cancer biology
For the first time, researchers have been able to grow, in a lab, both normal and primary cancerous prostate cells from a patient, and then implant a million of the cancer cells into a mouse to track how the tumor progresses.
Moffitt Cancer Center awarded $3.2 million grant to study bone metastasis in prostate cancer
Moffitt researchers David Basanta, Ph.D., and Conor Lynch, Ph.D., have been awarded a U01 grant to investigate prostate cancer metastasis.
New findings concerning hereditary prostate cancer
For the first time ever, researchers have differentiated the risks of developing indolent or aggressive prostate cancer in men with a family history of the disease.
Prostate cancer discovery may make it easier to kill cancer cells
A newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy.
New test for prostate cancer significantly improves prostate cancer screening
A study from Karolinska Institutet in Sweden shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
The dilemma of screening for prostate cancer
Primary care providers are put in a difficult position when screening their male patients for prostate cancer -- some guidelines suggest that testing the general population lacks evidence whereas others state that it is appropriate in certain patients.
Risk factors for prostate cancer
New research suggests that age, race and family history are the biggest risk factors for a man to develop prostate cancer, although high blood pressure, high cholesterol, vitamin D deficiency, inflammation of prostate, and vasectomy also add to the risk.
Prostate cancer is 5 different diseases
Cancer Research UK scientists have for the first time identified that there are five distinct types of prostate cancer and found a way to distinguish between them, according to a landmark study published today in EBioMedicine.
UH Seidman Cancer Center performs first-ever prostate cancer treatment
The radiation oncology team at UH Seidman Cancer Center in Cleveland performed the first-ever prostate cancer treatment April 3 using a newly-approved device -- SpaceOAR which enhances the efficacy of radiation treatment by protecting organs surrounding the prostate.

Related Prostate Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...